Welcome to our dedicated page for Forward Inds N Y SEC filings (Ticker: FORD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the numbers behind Forward Industries’ custom carrying cases or its MedTech design fees? This page groups every Forward Industries SEC filing explained simply, so you can move from question to answer in minutes—not hours.
Start with the essentials: the Forward Industries annual report 10-K simplified highlights OEM customer concentration, supply-chain risks in Asia, and segment margin details. Need quicker data? The Forward Industries quarterly earnings report 10-Q filing tracks revenue swings between design services and product sales. Sudden contract wins or factory interruptions appear in Forward Industries 8-K material events explained, while the DEF 14A proxy statement executive compensation reveals how management is paid for new MedTech wins.
Monitoring ownership moves is critical for a micro-cap like FORD. Our platform streams Forward Industries Form 4 insider transactions real-time, so you instantly spot fresh Forward Industries insider trading Form 4 transactions or other Forward Industries executive stock transactions Form 4. Every document arrives seconds after EDGAR posts, and Stock Titan’s AI generates plain-English summaries, ratio tables, and red-flag alerts—perfect for understanding Forward Industries SEC documents with AI. Whether you’re comparing quarter-over-quarter backlog, assessing material costs, or seeking Forward Industries earnings report filing analysis, the entire journey—from first search to decisive insight—happens right here, in one continuously updated feed.
Regulus Therapeutics Inc. filed Post-Effective Amendment No. 1 to 20 previously effective Form S-8 registration statements on 25 June 2025. The amendment deregisters all shares of common stock that had been registered but remain unsold or unissued under the company’s 2009, 2012, 2019 and 2021 equity incentive plans, multiple inducement plans and its 2012 and 2022 employee stock purchase plans. Collectively, the affected filings span registrations made between 2012 and 2025 and reference two reverse stock splits (1-for-12 in 2018 and 1-for-10 in 2022).
The action follows completion of the merger stipulated in the 29 April 2025 Agreement and Plan of Merger among Regulus, Novartis AG and Redwood Merger Sub Inc. On 25 June 2025, Redwood Merger Sub merged with and into Regulus, leaving Regulus as a wholly-owned subsidiary of Novartis. Because the company is now private, it has terminated all offerings of its securities, rendering the original S-8 registrations unnecessary.
Operationally, Regulus is identified as a non-accelerated filer and a smaller reporting company. No financial statements, valuation data or pro-forma disclosures are included; the filing is purely administrative. For investors, the document confirms the cessation of future share issuances under employee and incentive plans and provides final regulatory closure on Regulus’ transition from a public issuer to part of Novartis.
Forward Industries, Inc. (NASDAQ: FORD) has released its 2025 Definitive Proxy Statement (DEF 14A) for the virtual Annual Meeting scheduled on August 8, 2025. The document outlines eight proposals that shareholders of record on June 18, 2025 (1,125,998 common shares outstanding) will vote on.
Key Proposals:
- Proposal 1 – Election of three directors.
- Proposal 2 – Ratification of the independent registered public accounting firm for FY 2025.
- Proposal 3 – Reincorporation from New York to Nevada via a merger with a wholly-owned Nevada subsidiary (see Annex A).
- Proposal 4 – Nasdaq 20 % Issuance Proposal (ELOC): Approval to issue common shares above the 20 % threshold pursuant to a May 16 2025 equity line of credit agreement with C/M Capital Master Fund, LP.
- Proposal 5 – Nasdaq 20 % Issuance Proposal (Series B): Approval to issue shares upon conversion of Series B Preferred Stock and related warrants sold on May 23 2025 to two investors, again above the 20 % cap.
- Proposal 6 – 2021 Equity Incentive Plan Amendment: Increase share reserve by 300,000 to a total of 429,100 shares.
- Proposal 7 – Possible adjournment to solicit additional proxies if needed.
- Proposal 8 – Other business that may properly come before the meeting.
The meeting will be virtual-only via www.virtualshareholdermeeting.com/FWD2025; shareholders can vote in advance online, by phone, by mail, or during the webcast using their 16-digit control number.
Capital Structure Implications: Proposals 4, 5, and 6 collectively authorize a significant increase in share issuances, potentially diluting existing holders. The equity line of credit provides flexible access to capital, while the Series B conversion rights and the enlarged option pool expand financing and compensation tools.
Governance & Administrative Items: Reincorporation could align the company with Nevada’s more company-friendly statutes. No filing fee is required for this proxy, and the board recommends shareholders vote via Internet, telephone, mail, or during the meeting to ensure quorum.
FAQ
What is the current stock price of Forward Inds N Y (FORD)?
What is the market cap of Forward Inds N Y (FORD)?
What does Forward Inds Inc N Y specialize in?
How does the company generate revenue?
Who are the primary customers?
What industries does the company serve?
What materials are used in their products?
How does the company ensure product quality?
What differentiates Forward Inds Inc N Y from its competitors?
How does the company support its OEM clients?
